Silvia Baldari
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity.
Journal: Experimental hematology & oncology
Published: October 30, 2024
Expression pattern and prognostic significance of aldehyde dehydrogenase 2 in lung adenocarcinoma as a potential predictor of immunotherapy efficacy.
Journal: Cancer innovation
Published: January 03, 2024
The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 02, 2024
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.
Journal: Journal for immunotherapy of cancer
Published: August 08, 2023
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.
Journal: Cancers
Published: September 01, 2022
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.
Journal: Life science alliance
Published: July 04, 2022
HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer Progression.
Journal: Molecular cancer research : MCR
Published: August 04, 2021
Regenerative medicine approaches for the management of respiratory tract fistulas.
Journal: Stem cell research & therapy
Published: August 04, 2020
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 04, 2020
Current Biomedical Use of Copper Chelation Therapy.
Journal: International journal of molecular sciences
Published: January 09, 2020
Last Updated: 09/26/2026